eli lilly glp 1 drugs stock soars on encouraging results for daily weight-loss pill Lilly lowers self-pay prices of
Description
Treatment of type 2 diabetes with incretin-based therapies
Biobehav Rev
doi: 10.1016/S0140-6736(19)31149-3 18 GersteinHCSattarNRosenstockJRamasundarahettigeCPratleyRELopesRDet al
& Meier, J
The weight-loss journey is never just about weight
Hwang and A
